- Home
- ENLV vs VCIG Comparison
ENLV vs VCIG Comparison
Compare ENLV & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- VCIG
- Stock Information
- Founded
- ENLV 2005
- VCIG 2013
- Country
- ENLV Israel
- VCIG Malaysia
- Employees
- ENLV N/A
- VCIG N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- VCIG Diversified Commercial Services
- Sector
- ENLV Health Care
- VCIG Consumer Discretionary
- Exchange
- ENLV Nasdaq
- VCIG Nasdaq
- Market Cap
- ENLV 25.5M
- VCIG 22.5M
- IPO Year
- ENLV 1995
- VCIG 2023
- Fundamental
- Price
- ENLV $1.13
- VCIG $6.32
- Analyst Decision
- ENLV Strong Buy
- VCIG
- Analyst Count
- ENLV 2
- VCIG 0
- Target Price
- ENLV $10.00
- VCIG N/A
- AVG Volume (30 Days)
- ENLV 175.2K
- VCIG 325.9K
- Earning Date
- ENLV 08-29-2025
- VCIG 10-06-2025
- Dividend Yield
- ENLV N/A
- VCIG N/A
- EPS Growth
- ENLV N/A
- VCIG N/A
- EPS
- ENLV N/A
- VCIG 162.63
- Revenue
- ENLV N/A
- VCIG $32,903,041.00
- Revenue This Year
- ENLV N/A
- VCIG N/A
- Revenue Next Year
- ENLV N/A
- VCIG N/A
- P/E Ratio
- ENLV N/A
- VCIG $0.04
- Revenue Growth
- ENLV N/A
- VCIG 24.77
- 52 Week Low
- ENLV $0.81
- VCIG $6.01
- 52 Week High
- ENLV $2.10
- VCIG $4,644.00
- Technical
- Relative Strength Index (RSI)
- ENLV 57.20
- VCIG 54.10
- Support Level
- ENLV $1.01
- VCIG $6.01
- Resistance Level
- ENLV $1.08
- VCIG $7.22
- Average True Range (ATR)
- ENLV 0.04
- VCIG 0.83
- MACD
- ENLV 0.02
- VCIG -0.42
- Stochastic Oscillator
- ENLV 87.86
- VCIG 6.26
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.